TriFlo Cardiovascular, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.triflocv.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Transcatheter Treatment of Tricuspid Valve Regurgitation
Not Applicable
Not yet recruiting
- Conditions
- Symptomatic Severe Tricuspid Regurgitation
- First Posted Date
- 2023-10-23
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- TriFlo Cardiovascular, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT06093828
- Locations
- 🇮🇹
Pineta Grande Hospital, Castel Volturno, Caserta, Italy
🇮🇹IRCCS Humanitas Research Hospital, Rozzano, Milano, Italy
🇮🇹IRCCS Policlinico San Donato, San Donato Milanese, Milano, Italy
News
No news found